Liver Biopsy Size Matters in Chronic Hepatitis: Bigger Is Better
2003; Lippincott Williams & Wilkins; Volume: 38; Issue: 6 Linguagem: Inglês
10.1016/j.hep.2003.10.010
ISSN1527-3350
Autores Tópico(s)Hepatitis B Virus Studies
ResumoHepatologyVolume 38, Issue 6 p. 1356-1358 EditorialFree Access Liver biopsy size matters in chronic hepatitis: Bigger is better Peter J. Scheuer M.D., Corresponding Author Peter J. Scheuer M.D. [email protected] Department of Histopathology, Royal Free Hospital, London, UK47 Northway, London NW11 6PB, United Kingdom; fax: (44) 20 8455 4383===Search for more papers by this author Peter J. Scheuer M.D., Corresponding Author Peter J. Scheuer M.D. [email protected] Department of Histopathology, Royal Free Hospital, London, UK47 Northway, London NW11 6PB, United Kingdom; fax: (44) 20 8455 4383===Search for more papers by this author First published: 30 December 2003 https://doi.org/10.1016/j.hep.2003.10.010Citations: 68AboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onEmailFacebookxLinkedInRedditWechat No abstract is available for this article. References 1 The French METAVIR Cooperative Study Group. Intraobserver and interobserver variations in liver biopsy interpretation in patients with chronic hepatitis C. Hepatology 1994; 20: 15–20. 10.1002/hep.1840200104 PubMedWeb of Science®Google Scholar 2 Ishak K, Baptista A, Bianchi L, Callea F, De Groote J, Gudat F, Denk H, et al. Histological grading and staging of chronic hepatitis. J Hepatol 1995; 22: 696–699. 10.1016/0168-8278(95)80226-6 CASPubMedWeb of Science®Google Scholar 3 Colloredo G, Guido M, Sonzogni A, Leandro G. Impact of liver biopsy size on histological evaluation of chronic viral hepatitis: the smaller the sample, the milder the disease. J Hepatol 2003; 39: 239–244. 10.1016/S0168-8278(03)00191-0 PubMedWeb of Science®Google Scholar 4 Manabe N, Chevallier M, Chossegros P, Causse X, Guerret S, Trépo C, Grimaud J-A. Interferon-alpha 2b therapy reduces liver fibrosis in chronic non-A, non-B hepatitis: a quantitative histological evaluation. Hepatology 1993; 18: 1344–1349. 10.1002/hep.1840180610 CASPubMedWeb of Science®Google Scholar 5 Chevallier M, Guerret S, Chossegros P, Gerard F, Grimaud J-A. A histological semiquantitative scoring system for evaluation of hepatic fibrosis in needle liver biopsy specimens: comparison with morphometric studies. Hepatology 1994; 20: 349–355. 10.1002/hep.1840200213 CASPubMedWeb of Science®Google Scholar 6 Poynard T, Bedossa P, Opolon P. Natural history of liver fibrosis progression in patients with chronic hepatitis C. Lancet 1997; 349: 825–832. 10.1016/S0140-6736(96)07642-8 CASPubMedWeb of Science®Google Scholar 7 Rozario R, Ramakrishna B. Histopathological study of chronic hepatitis B and C: a comparison of two scoring systems. J Hepatol 2003; 38: 223–229. 10.1016/S0168-8278(02)00357-4 PubMedWeb of Science®Google Scholar 8 Duchatelle V, Marcellin P, Giostra E, Bregeaud L, Pouteau M, Boyer N, Auperin A, et al. Changes in liver fibrosis at the end of alpha interferon therapy and 6 to 18 months later in patients with chronic hepatitis C: quantitative assessment by a morphometric method. J Hepatol 1998; 29: 20–28. 10.1016/S0168-8278(98)80174-8 CASPubMedWeb of Science®Google Scholar 9 Smith BC, Grove J, Guzail MA, Day CP, Daly AK, Burt AD, Bassendine MF. Heterozygosity for hereditary hemochromatosis is associated with more fibrosis in chronic hepatitis C. Hepatology 1998; 27: 1695–1699. 10.1002/hep.510270631 CASPubMedWeb of Science®Google Scholar 10 Berenguer M, Ferrell L, Watson J, Prieto M, Kim M, Rayón M, Córdoba J, et al. HCV-related fibrosis progression following liver transplantation: increase in recent years. J Hepatol 2000; 32: 673–684. 10.1016/S0168-8278(00)80231-7 CASPubMedWeb of Science®Google Scholar 11 Kage M, Shimamatu K, Nakashima E, Kojiro M, Inoue O, Yano M. Long-term evolution of fibrosis from chronic hepatitis to cirrhosis in patients with hepatitis C: morphometric analysis of repeated biopsies. Hepatology 1997; 25: 1028–1031. 10.1002/hep.510250439 CASPubMedWeb of Science®Google Scholar 12 Kaserer K, Fiedler R, Steindl P, Müller Ch, Wrba F, Ferenci P. Liver biopsy is a useful predictor of response to interferon therapy in chronic hepatitis C. Histopathology 1998; 32: 454–461. 10.1046/j.1365-2559.1998.00413.x CASPubMedWeb of Science®Google Scholar 13 Bravo AA, Sheth SG, Chopra S. Liver biopsy. N Engl J Med 2001; 344: 495–500. 10.1056/NEJM200102153440706 CASPubMedWeb of Science®Google Scholar 14 Zarski JP, McHutchison J, Bronowicki JP, Sturm N, Garcia-Kennedy R, Hodaj E, Truta B, et al. Rate of natural disease progression in patients with chronic hepatitis C. J Hepatol 2003; 38: 307–314. 10.1016/S0168-8278(02)00387-2 PubMedWeb of Science®Google Scholar 15 Afdhal NH. Diagnosing fibrosis in hepatitis C: is the pendulum swinging from biopsy to blood tests? Hepatology 2003; 37: 972–974. 10.1053/jhep.2003.50223 PubMedWeb of Science®Google Scholar 16 Poynard T, McHutchison J, Manns M, Myers RP, Albrecht J. Biochemical surrogate markers of liver fibrosis and activity in a randomized trial of peginterferon alfa-2b and ribavirin. Hepatology 2003; 38: 481–492. 10.1053/jhep.2003.50319 CASPubMedWeb of Science®Google Scholar 17 Lagging LM, Westin J, Svensson E, Aires N, Dhillon AP, Lindh M, Westjal R, et al. Progression of fibrosis in untreated patients with hepatitis C virus infection. Liver 2002; 22: 136–144. 10.1034/j.1600-0676.2002.01623.x PubMedWeb of Science®Google Scholar 18 Pilette C, Rousselet MC, Bedossa P, Chappard D, Oberti F, Rifflet H, Maıga MY, et al. Histopathological evaluation of liver fibrosis: quantitative image analysis vs semi-quantitative scores. J Hepatol 1998; 28: 439–446. 10.1016/S0168-8278(98)80318-8 CASPubMedWeb of Science®Google Scholar 19 Masseroli M, Caballero T, O'Valle F, Del Moral RM, Pérez-Milena A, Del Moral RG. Automatic quantification of liver fibrosis: design and validation of a new image analysis method: comparison with semi-quantitative indexes of fibrosis. J Hepatol 2000; 32: 453–464. 10.1016/S0168-8278(00)80397-9 CASPubMedWeb of Science®Google Scholar 20 O'Brien MJ, Keating NM, Elderiny S, Cerda S, Keaveny AP, Afdhal NH, Nunes DP. An assessment of digital image analysis to measure fibrosis in liver biopsy specimens of patients with chronic hepatitis C. Am J Clin Pathol 2000; 114: 712–718. 10.1309/D7AU-EYW7-4B6C-K08Y CASPubMedWeb of Science®Google Scholar Citing Literature Volume38, Issue6December 2003Pages 1356-1358 ReferencesRelatedInformation
Referência(s)